Navigation Links
Mutant Genes in High-Risk Childhood Leukemias Identified
Date:5/19/2009

Results of collaborative study could lead to development of new diagnostic tools and a new therapeutic target in high-risk disease

MEMPHIS, Tenn., May 19 /PRNewswire-USNewswire/ -- A research team has pinpointed a new class of gene mutations, which identify cases of childhood acute lymphoblastic leukemia (ALL) that have a high risk of relapse and death. The finding suggests specific drugs that could treat this high-risk leukemia subtype in children, particularly because such drugs are already in clinical trials for similar blood diseases in adults.

While the cure rate in pediatric ALL has reached about 85 percent, the remaining high-risk cases have proven especially intractable because they arise from different, unidentified genetic mutations.

Discovery of the mutations was led by scientists from St. Jude Children's Research Hospital, the Children's Oncology Group (COG), the University of New Mexico Cancer Research and Treatment Center, Albuquerque, N.M., and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). This research was done as part of the NCI Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative, which seeks to utilize the study of genomics to identify therapeutic targets in order to develop more effective treatments for childhood cancers. The article appears online May 18 in the early edition of the Proceedings of the National Academy of Sciences.

"We have made such great progress in curing children with ALL that the main challenge is now the remaining high-risk patients," said St. Jude Scientific Director, James Downing, M.D., a co-senior author of the study. "We still do not know how to accurately identify these patients and effectively treat them to provide the highest chance for a cure. The problem is that this high-risk group is likely a heterogeneous mixture of biologic subtypes."

<
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
2. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
3. Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice
4. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
5. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
6. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
7. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
8. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
9. Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
10. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
11. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (the "Company") (NASDAQ: CLSN ) today announced ... purchase an aggregate of approximately $15 million of the ... led by a dedicated health care fund. ... investors pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... a Little Help ... Series,PSA Expands Partnership Between VH1 and Nothing But Nets to Prevent Malaria ... in Africa, ... very serious issue in a new Public,Service Announcement (PSA) created by VH1 for Nothing But ...
... Immtech Pharmaceuticals,Inc. (Amex: IMM ) today announced ... consortium led by the University of North Carolina ... Bill & Melinda Gates Foundation,(the "Gates Foundation"), to ... leishmania. This grant is part of the $22.6,million ...
Cached Medicine Technology:'Best Week Ever' for Nothing But Nets 2'Best Week Ever' for Nothing But Nets 3Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3
(Date:4/18/2014)... Ky. (April 21, 2014) -- A group of ... Medicine and the Sanders-Brown Center on Aging has ... depression and neuropsychological function in Parkinson,s disease (PD). ... Research , the study, which assessed cognitive function ... that the dopamine replacement therapy commonly used to ...
(Date:4/18/2014)... memories? How did it make you feel? According to ... experience, such as how sad you were or how ... when you can,t stop thinking about it. , ... context of the memories, rather than how you felt, ... the negative effects of these memories, a new study ...
(Date:4/18/2014)... Medicine scientists could lead to potential new treatments for ... scleroderma. , Fibrosis, or scarring, is a hallmark ... and lungs can lead to serious organ damage and, ... therapeutic options centers on findings made by Swati Bhattacharyya, ... role that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial ... School of Medicine, variations of the adiponectin gene, which ... womans risk of developing breast cancer. This discovery is ... it could help experts develop a future genetic testing ...
... NEW YORK (April 25, 2008) -- Heart failure patients ... first to be implanted with the HeartMate II LVAS ... that helps weak hearts pump blood -- that has ... 21 for broad use as bridge to transplantation. As ...
... County Sees Sharp Rise in Gonorrhea Cases, HARRISBURG, Pa., ... of cases of Gonorrhea last year in Delaware County,the Pennsylvania ... of 15 and 24 be routinely screened for the,disease, as ... Gonorrhea grew to 921 in 2007 from 513,the year before., ...
... With an aggressive growth plan in,effect for 2008, YoNaturals ... big step in their expansion efforts with new,vending locations ... of 2006, YoNaturals has maintained a strong,dedication toward changing ... have experienced thus far is in large part due ...
... Winner Renee Zellweger ("Chicago") Reteams with Craig Zadan and Neil Meron, Executive ... Producers for the Sony Pictures Television Project, Based ... a Doctor,s Dramatic Quest to Develop the Lifesaving Breast Cancer ... Drug Herceptin ...
... The Lupus Foundation of,America joins a coalition of approximately ... on May 10. More than 1.5 million,Americans and at ... they struggle daily with the often-debilitating health,consequences of the ... of an unbalanced immune system that can become,destructive to ...
Cached Medicine News:Health News:Study shows gene variations may predict risk of breast cancer in women 2Health News:FDA approves HeartMate II mechanical heart pump for heart-failure patients 2Health News:Gulfport-Biloxi Airport Welcomes Installation of New YoNaturals Healthy Vending Machines 2Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 2Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 3Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 4Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 5Health News:Lupus Organizations Issue International Call-to-Action to Combat Disease Affecting Five Million People 2
Three-spring evacuator kits with silicone drains, 10 in. hole pattern, trocar and Y-connector tubing...
Provides reliable suction for surgical cases with larger amounts of drainage....
Offers a more constant suction profile than three-spring evacuators, resulting in the potential for improved tissue approximation and reduced risk of hematoma....
Reliavac® 400cc kits with siliconized PVC drain, Y-connector tube...
Medicine Products: